au.\*:("ELISAF, M")
Results 1 to 25 of 137
Selection :
Effects of fibrates on serum metabolic parametersELISAF, M.Current medical research and opinion. 2002, Vol 18, Num 5, pp 269-276, issn 0300-7995Article
Are the Pleiotropic Effects of Drugs Used for the Prevention of Cardiovascular Disease Clinically Relevant?ELISAF, M; LIBEROPOULOS, E. N.Current pharmaceutical design (Print). 2009, Vol 15, Num 5, issn 1381-6128, 123 p.Serial Issue
Syndrome of inappropriate antidiuresis associated with multiple sclerosisLIAMIS, G; ELISAF, M.Journal of the neurological sciences. 2000, Vol 172, Num 1, pp 38-40, issn 0022-510XArticle
Fractional excretion of potassium in normal subjects and in patients with hypokalaemiaELISAF, M; SIAMOPOULOS, K. C.Postgraduate medical journal. 1995, Vol 71, Num 834, pp 211-212, issn 0032-5473Article
Pleiotropic Effects of FenofibrateTSIMIHODIMOS, V; LIBEROPOULOS, E; ELISAF, M et al.Current pharmaceutical design (Print). 2009, Vol 15, Num 5, pp 517-528, issn 1381-6128, 12 p.Article
Cola-induced hypokalaemia: pathophysiological mechanisms and clinical implicationsTSIMIHODIMOS, V; KAKAIDI, V; ELISAF, M et al.International journal of clinical practice (Esher). 2009, Vol 63, Num 6, pp 900-902, issn 1368-5031, 3 p.Article
Prevention and Treatment of the metabolic syndromeDASKALOPOULOU, S. S; MIKHAILIDIS, D. P; ELISAF, M et al.Angiology. 2004, Vol 55, Num 6, pp 589-612, issn 0003-3197, 24 p.Article
Platelet aggregatory response to platelet activating factor (PAF), ex vivo, and PAF-acetylhydrolase activity in patients with unstable angina : effect of c7E3 Fab (abciximab) therapyTSELEPIS, A. D; GOUDEVENOS, J. A; TAMBAKI, A. P et al.Cardiovascular research. 1999, Vol 43, Num 1, pp 183-191, issn 0008-6363Article
Serum magnesium levels in patients undergoing chronic ambulatory peritoneal dialysisELISAF, M; KATOPODIS, K; KATSARAKI, A et al.Trace elements and electrolytes. 1998, Vol 15, Num 3, pp 155-158, issn 0946-2104Article
Successful treatment of hyponatremia with angiotensin-converting enzyme inhibitors in patients with congestive heart failureELISAF, M; THEODOROU, J; PAPPAS, C et al.Cardiology. 1995, Vol 86, Num 6, pp 477-480, issn 0008-6312Article
Pathogenetic mechanisms of hypomagnesemia in alcoholic patientsELISAF, M; MERKOUROPOULOS, M; TSIANOS, E. V et al.Journal of trace elements and electrolytes in health and disease. 1995, Vol 9, Num 4, pp 210-214, issn 0931-2838Conference Paper
The value of α-amylase and isoamylase determination in chronic renal failure patientsTSIANOS, E. V; DARDAMANIS, M. A; ELISAF, M et al.International journal of pancreatology. 1994, Vol 15, Num 2, pp 105-111, issn 0169-4197Article
Enterococcus casseliflavus bacteremia. Case report and literature reviewPAPPAS, G; LIBEROPOULOS, E; TSIANOS, E et al.The Journal of infection. 2004, Vol 48, Num 2, pp 206-208, issn 0163-4453, 3 p.Article
Cutaneous manifestations in brucellosis : Case report and review of the literatureMILIONIS, H; CHRISTOU, L; ELISAF, M et al.Infection. 2000, Vol 28, Num 2, pp 124-126, issn 0300-8126Article
Ezetimibe-associated adverse effects : what the clinician needs to knowFLORENTIN, M; LIBEROPOULOS, E. N; ELISAF, M. S et al.International journal of clinical practice (Esher). 2008, Vol 62, Num 1, pp 88-96, issn 1368-5031, 9 p.Article
Hyponatraemia in a patient with hepatic cirrhosisMILIONIS, H. J; ELISAF, M. S.Nephrology, dialysis, transplantation (Print). 1999, Vol 14, Num 3, pp 787-789, issn 0931-0509Article
Hyperosmolar nonketotic syndrome with hypernatremia : How can we monitor treatment?LIAMIS, G; GIANOUTSOS, C; ELISAF, M. S et al.Diabetes & metabolism. 2000, Vol 26, Num 5, pp 403-405, issn 1262-3636Article
Multiple electrolyte abnormalities after pamidronate administrationELISAF, M; KALAITZIDIS, R; SIAMOPOULOS, K. C et al.Nephron. 1998, Vol 79, Num 3, pp 337-339, issn 0028-2766Article
Hypophosphataema in a patient with Gitelman's syndromeKATOPODIS, K; ELISAF, M; SIAMOPOULOS, K. C et al.Nephrology, dialysis, transplantation (Print). 1996, Vol 11, Num 10, pp 2090-2092, issn 0931-0509Article
Chronic renal dysfunction in hemorrhagic fever with renal syndrome patientsELISAF, M; KARAKIS, H; SIAMOPOULOS, K. C et al.Renal failure. 1993, Vol 15, Num 5, pp 623-627, issn 0886-022XConference Paper
Acid-base abnormalities in a patient with hepatic cirrhosisMILIONIS, H. J; ELISAF, M. S.Nephrology, dialysis, transplantation (Print). 1999, Vol 14, Num 6, pp 1599-1601, issn 0931-0509Article
Psoriasiform lesions as paraneoplastic manifestation in Hodgkin's diseaseMILIONIS, H. J; ELISAF, M. S.Annals of oncology. 1998, Vol 9, Num 4, pp 449-452, issn 0923-7534Article
Retrosternal abscess : A prominent manifestation of infection due to Staphylococcus aureusMILIONIS, H; TATSIS, C; ELISAF, M et al.Clinical infectious diseases. 1998, Vol 26, Num 6, pp 1462-1464, issn 1058-4838Conference Paper
Lp(a) levels in Greek patients with heterozygous familial hypercholesterolemiaELISAF, M; BAIRAKTARI, H; SIAMOPOULOS, K. C et al.International journal of cardiology. 1996, Vol 53, Num 3, pp 314-316, issn 0167-5273Article
Pleiotropic Effects of Drugs Inhibiting the Renin-Angiotensin-Aldosterone SystemJANKOWSKI, P; SAFAR, M. E; BENETOS, A et al.Current pharmaceutical design (Print). 2009, Vol 15, Num 5, pp 571-584, issn 1381-6128, 14 p.Article